SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-22-016097
Filing Date
2022-08-09
Accepted
2022-08-09 16:22:52
Documents
15
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-K/A me-20220331.htm   iXBRL 10-K/A 219270
2 EX-31.1 me-ex31_1.htm EX-31.1 20946
3 EX-31.2 me-ex31_2.htm EX-31.2 20950
  Complete submission text file 0000950170-22-016097.txt   518116

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT me-20220331_lab.xml EX-101.LAB 32158
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT me-20220331.xsd EX-101.SCH 3103
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT me-20220331_def.xml EX-101.DEF 20560
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT me-20220331_pre.xml EX-101.PRE 21272
9 EXTRACTED XBRL INSTANCE DOCUMENT me-20220331_htm.xml XML 11908
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 10-K/A | Act: 34 | File No.: 001-39587 | Film No.: 221148682
SIC: 2834 Pharmaceutical Preparations